On October 31st, the second session of the Boao Forum on Economic and Social Security held a special docking meeting on the health industry module of multinational corporations in Changsha and Jinan University in Liuyang Economic and Technological Development Zone. More than 140 industry experts, elites, and industry leaders, including multinational enterprises, economic and trade institutions, and Changsha enterprises, gathered in Liuyang to discuss opportunities and seek high-quality development of the big health industry. This event has successively held a bio industry promotion conference and a bio industry development conference. At the morning promotion meeting, officials from Liuyang Economic and Technological Development Zone, Jinxia Economic and Technological Development Zone, and Tianxin District National Medical Center respectively promoted their respective parks, projects, and policies, showcasing their respective advantages and offering olive branches, sincerely inviting guests to invest and prosper in Chang'an. The biopharmaceutical products in the park cover multiple fields such as chemical raw materials and preparations, pharmaceutical excipients, modern Chinese medicine, biological products, medical devices, functional health products and food, animal medicine and health products, with over 800 varieties and 11 flagship varieties sold for over 100 million yuan, forming an annual output value of 30 billion yuan, At the beginning of this year, the park also formulated a special policy for the biopharmaceutical industry, providing support from fixed investment, clinical trials, new drug registration, talent introduction, investment financing, R&D innovation, and other aspects. A single policy can reward up to 25 million yuan. In the context of economic globalization, global enterprises, economic and trade institutions, etc. are seeking new development opportunities. At the promotion meeting, representatives from Huada Group, Hong Kong Trade Development Council, Jiudian Pharmaceutical, Hengchang Pharmaceutical Group, and Changsha Renji Medical delivered speeches, and focused on promoting and releasing cooperation needs on site. The speaking representatives all expressed that the big health industry is a promising "sunrise industry", and they hope that both sides can take this event as an opportunity to deepen communication and cooperation, seize industry opportunities, create more exchange and cooperation results, and achieve more mutually beneficial and win-win two-way cooperation. At the afternoon bio industry development conference, industry experts had in-depth discussions on topics such as drug supervision and industry development under the new situation, new medical reform development trends and enterprise response discussions, and the current status and development trends of improved new drugs. At the same time, representatives of multinational enterprises also visited and conducted research on platforms and enterprises such as Hunan Prima Pharmaceutical Research Center Co., Ltd., Tiandi Hengyi Pharmaceutical Co., Ltd., and Hunan Jiudian Pharmaceutical Co., Ltd. in Liuyang Economic and Technological Development Zone. Dr. Evelyn Maria Bishop from Germany is the deputy chief physician of Shanghai Renji Hospital and a collaborative expert of Yingsi Intelligent Technology (Shanghai) Co., Ltd. She told Xinhua News Agency that she hopes to participate in the Boao Forum on Economic Security and explore the development issues facing the world with professionals from various fields. China is a country that is good at cooperation and also holds a leading position in the application of artificial intelligence in the field of medicine. We look forward to exploring new development strategies through international cooperation and utilizing artificial intelligence. "▲ Dr. Evelyn Maria Bishop, Deputy Chief Physician of Shanghai Renji Hospital and Collaborative Expert of Yingsi Intelligent Technology (Shanghai) Co., Ltd. (Xinhua News Agency)